secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001628280-24-000199
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics CFO Allan Reine resigns effective Jan 16, 2024
-------------------------------------------------------------------

- CFO Allan Reine resigns to pursue other opportunity; effective Jan 16, 2024.
- Departure not due to any disagreement with company's operations, policies, or financial controls.
- Company has commenced formal search for a successor; CEO thanked Reine for his leadership.
- Dr. Reine's last full-time day will be January 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/0001628280-24-000199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024000199/fhtx-20231229.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-000199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer